MHI-RJ-AVIATION-GROUP
20.7.2022 18:34:04 CEST | Business Wire | Press release
MHI RJ Aviation Group (MHIRJ) has announced today at the Farnborough Air Show the signing of an agreement with Air Nostrum Engineering and Maintenance (ANEM), appointing them as a MHIRJ Authorized Service Facility (ASF) in Europe. This agreement marks an important step in expanding MHIRJ’s service network internationally, allowing MHIRJ to extend, in collaboration with ANEM, the same levels of service that customers in North America receive through its wholly owned service centers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220720005641/en/
This agreement expands MHIRJ’s existing ASF support structure in Europe, introducing diversity and additional capacity to the existing network. ANEM’s addition will serve to meet the growing demands of the market, offering a wider array of availability and options for the European sector as well as for MHIRJ customers worldwide.
Based in Valencia (Spain), ANEM is part of the group of companies fully owned by the same shareholders of the airline Air Nostrum. ANEM currently serves as MRO and aircraft maintenance services provider for multiple airlines based in Europe, Africa, and Latin America. Air Nostrum has been operating CRJ Series aircraft since the year 1998 and currently operates the largest CRJ Series fleet in Europe, accounting for 37 CRJ Series aircraft. Air Nostrum is a ten-time MHIRJ Customer Reliability Award winner and a multiple time winner of the ERA Airline of the Year. Their vast operational experience will provide a first-rate base to support the CRJ Series fleet in Europe and across the world. Combining the strengths of ANEM and MHIRJ will bring forth our world-class Aftermarket network to the next level, providing our customers the full suite of MRO services.
Hiro Yamamoto, President and CEO of MHIRJ, commented “We are extremely proud to announce this agreement with Air Nostrum which will benefit customers in the European region, allowing them to access strong MRO support close to home. Reliability has always been the CRJ Series fleet’s strong suit; this agreement maintains that reliability and ensures an even stronger commitment to our customers.”
“ANEM brings a versatile set of capabilities that substantially enhances the CRJ Series MRO support for our European and International customers. As the maintenance arm of the largest CRJ Series carrier in Europe; our strategic collaboration with ANEM favorably positions us to collectively grow and expand support outside of North America,” commented Ismail Mokabel, Senior Vice-President and Head of Aftermarket at MHIRJ.
Amel Belkhamsa, Head of Aftermarket Commercial Services and Spare Parts Operations at MHIRJ, added “This is the first step in broadening our relationship with Air Nostrum to provide support to MHIRJ’s customers outside of North America. We wanted to find an MRO with a large range of capabilities to open the door to even more potential future collaboration, such as in the areas of material support and field response services, to ensure that all our international customers receive the best support available.”
Miguel Falcon, Vice Chairman of Air Nostrum and ANEM, said: “We are delighted to strengthen our cooperation with MHIRJ via this ASF agreement as its next Authorized MRO. We have 24 years of experience with the CRJ Series and have provided exceptional reliability for our customers, and this is due largely to the great relationship that we have with MHIRJ.”
Fermin Tirado, General Manager of ANEM, commented: “Thanks to the dedication and exceptional skills of our team members at ANEM, we´re quite pleased to sign this ASF agreement with MHIRJ that enhances our long-established partnership, allows us to increase the number of employees in ANEM, and grow our capacity for our airline customers.”
About Air Nostrum Group
Air Nostrum Group comprises different companies related to air transport and mobility including airlines, high speed railway transportation and firefighting, as well as related services companies: maintenance, training, flight support etc. The Group flagship, Air Nostrum Líneas Aereas, based in Spain, operates over 70,000 flights carrying more than 4,7 million passengers each year, being the leading regional aviation company in Spain and one of the largest in Europe. It operates for the Iberia Group under the Iberia Regional Air Nostrum brand, has sales over 500 million euros and employs more than 1,400 people.
About ANEM
ANEM is a PART 145 MRO (ES.145.060) and CAMO (ES.CAMO.059) company that arises from the split of AIR NOSTRUM’s business activities. ANEM performs the whole maintenance of the Air Nostrum’s Group fleets, including Air Nostrum, Hibernian, Melair, Paranair and PLYSA. These fleets are: CRJ200, CRJ900, CRJ1000, ATR72-600, and THRUSH S2R-T660. ANEM has a modern Hangar in Valencia Airport in order to cover all maintenance phases of the Air Nostrum’s Group and other operators’ fleets.
About MHI RJ Aviation Group
MHI RJ Aviation Group (MHIRJ) provides comprehensive critical operational, engineering and customer support solutions including maintenance, refurbishment, technical publications, marketing and sales activities for the global regional aircraft industry. Headquartered in Montréal, Canada, and bolstered by an Aerospace Engineering Centre, MHIRJ’s network of service centers, support offices and parts depots are positioned in important aviation hubs in Canada, the U.S. and Germany. A wholly owned subsidiary of Mitsubishi Heavy Industries, Ltd., MHI RJ Aviation Group includes MHI RJ Aviation ULC (Canada), MHI RJ Aviation Inc. (U.S.A.) and MHI RJ Aviation GmbH (Germany).
WE ARE HIRING. Visit mhirj.com/en/careers to know more.
For more information about MHI RJ Aviation Group, please visit: mhirj.com or follow our insights and stories on wingspan.mhirj.com
About MHI Group
Mitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, logistics & infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life, and ensure a safer world.
For more information, please visit www.mhi.com or follow our insights and stories on www.spectra.mhi.com
*CRJ, CRJ Series and MHIRJ are trademarks of MHI RJ Aviation ULC or its affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220720005641/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom